Ken‐ichi Ito
- Oncology top 2%
- Molecular Biology top 10%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Roger G. DeeleySusan P.C. ColeJun AmanoYoshio YasumuraMasakazu YamagishiMaiko FujimoriTakaaki ObaSatoshi Nakatani
- Topics
- Thyroid Cancer Diagnosis and Treatment (32 papers)Liver Disease Diagnosis and Treatment (12 papers)Cancer-related Molecular Pathways (11 papers)
- Partner nations
- JapanCanadaUnited States
In The Last Decade
Ken‐ichi Ito
184 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 132
- Oncology 1.1k
- Molecular Biology 1.1k
- Surgery 902
- Pulmonary and Respiratory Medicine 763
- Radiology, Nuclear Medicine and Imaging 518
Countries citing papers authored by Ken‐ichi Ito
This map shows the geographic impact of Ken‐ichi Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Ito more than expected).
Fields of papers citing papers by Ken‐ichi Ito
This network shows the impact of papers produced by Ken‐ichi Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Ito. The network helps show where Ken‐ichi Ito may publish in the future.
Co-authorship network of co-authors of Ken‐ichi Ito
This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Ito. A scholar is included among the top collaborators of Ken‐ichi Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Ito. Ken‐ichi Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 32 | |
| 3 | 14 | |
| 4 | 27 | |
| 5 | Factors Influencing the Chemo-Sensitivity of Weekly Paclitaxel for Anaplastic Thyroid Cancer: A Clinico-Pathologic Analysis of Cases Enrolled in a Clinical Trial | 1 |
| 6 | 1 | |
| 7 | 27 | |
| 8 | [A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer]. | 2 |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 7 | |
| 12 | 0 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 1 | |
| 17 | 0 | |
| 18 | A new prostacyclin analogue - an anticoagulant applicable to hemodialysis. | 8 |
| 19 | 1 | |
| 20 | 1 |
About Ken‐ichi Ito
Ken‐ichi Ito is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Hepatology, having authored 195 papers that have together received 3.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (32 papers), Liver Disease Diagnosis and Treatment (12 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Oncology (1.1k citations), Endocrinology, Diabetes and Metabolism (455 citations) and Cancer Research (372 citations). Ken‐ichi Ito has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Roger G. Deeley, Susan P.C. Cole, Jun Amano, Yoshio Yasumura, Masakazu Yamagishi, Maiko Fujimori, Takaaki Oba, Satoshi Nakatani, Kazuma Maeno and Kunio Miyatake. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.